D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q2 2026)
- 95,540
- Value
- $1.62M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 95,540 | $1.62M | <0.1% | +2,280+2.4% | Added | Holders |
| Q1 2026 | 93,260 | $1.20M | <0.1% | +9,260+11.0% | Added | Holders |
| Q4 2025 | 84,000 | $755.2K | <0.1% | +19,780+30.8% | Added | Holders |
| Q3 2025 | 64,220 | $1.11M | <0.1% | +10,100+18.7% | Added | Holders |
| Q2 2025 | 54,120 | $507.6K | <0.1% | +28,100+108.0% | Added | Holders |
| Q1 2025 | 26,020 | $185.0K | <0.1% | +11,250+76.2% | Added | Holders |
| Q4 2024 | 14,770 | $172.2K | <0.1% | −1,480−9.1% | Reduced | Holders |
| Q3 2024 | 16,250 | $333.9K | <0.1% | +4,150+34.3% | Added | Holders |
| Q2 2024 | 12,100 | $270.8K | <0.1% | +12,100 | New | Holders |